Skip to main content
. 2014 Jul 30;15(8):13299–13316. doi: 10.3390/ijms150813299

Table 2.

Pathological characteristics of the tumors in prostatectomy specimens and correlations with serum PSA (Prostate-Specific Antigen), PHI (Prostate Health Index), urinary PCA3 (Prostate Cancer gene 3) and T2 (TMPRSS2:ERG) scores.

Pathological Characteristics Prostatectomy
(Number of Patients)
Number of Patients (%) Serum PSA PCA3 Score T2 Score PHI
Median (IQR) p Value Median (IQR) p Value Median (IQR) p Value Median (IQR) p Value
Pathological T stage
n = 154
pT2
n = 106 (69%)
6.5
(5.0–9.0)
0.467 47
(23–82)
0.724 27
(5–106)
0.027 41
(32–53)
0.086
≥pT3
n = 48 (31%)
6.4
(5.2–10.9)
40
(25–111)
52
(10–352)
47
(34–59)
Gleason stage
n = 154
G6
n = 22 (14%)
6.5
(4.6–11.0)
0.739 47
(23–81)
0.897 38
(6–148)
0.123 34
(31–40)
0.013
G ≥ 7
n = 132 (86%)
6.5
(5.2–9.3)
43
(23–90)
35
(7–151)
44
(34–57)
Total tumor volume (mL) a
n = 153
<0.5
n = 19 (12%)
6.2
(4.1–10.1)
0.276 23
(15–47)
0.004 14
(1–105)
0.090 32
(27–42)
0.002
≥0.5
n = 134 (88%)
6.5
(5.1–9.3)
48
(25–94)
37
(6–154)
44
(34–57)
Number of tumor foci
n = 154
Uni
n = 41 (27%)
6.1
(4.3–11.0)
0.230 27
(19–49)
0.002 55
(8–178)
0.299 41
(33–52)
0.410
Multi
n = 113 (73%)
6.6
(5.4–9.2)
51
(27–94)
33
(3–127)
43
(33–57)
Blood embols
n = 154
No
n = 148 (96%)
6.5
(5.0–9.1)
0.030 44
(23–85)
0.253 35
(5–138)
0.709 42
(33–55)
0.009
Yes
n = 6 (4%)
12.9
(8.6–18.1)
103
(25–148)
20
(2–164)
79
(46–140)
Positive resection margins
n = 154
R0
n = 121 (79%)
6.3
(5.0–8.8)
0.029 42
(23–82)
0.241 36
(5–137)
0.620 40
(32–53)
0.007
R1
n = 33 (21%)
7.8
(5.9–14.1)
61
(26–110)
29
(3–214)
50
(41–65)

Abbreviations: IQR: interquartile range; PCA3: prostate cancer gene 3; PHI: Prostate Health Index; PSA: prostate-specific antigen; T2: TMPRSS2:ERG fusion gene; a: median total tumor volume = 2.2 (IQR: 0.9–4.1).